Frequent glucose monitoring is a fundamental part of diabetes management, and good
glucose control is important for long-term health outcomes. New types of electrochemical …

Incredible strides have been made since the discovery of insulin almost 100 years ago.
Insulin formulations have improved dramatically, glucose levels can be measured …

Objective To evaluate the performance of the FreeStyle Libre Flash continuous glucose
monitoring (FSL-CGM) system against established central laboratory methods. Research …

Cellular therapies for type-1 diabetes can leverage cell encapsulation to dispense with
immunosuppression. However, encapsulated islet cells do not survive long, particularly …

To diminish the learning curve associated with using swine as models, Swine in the
Laboratory: Surgery, Anesthesia, Imaging, and Experimental Techniques, Second Edition …

Recent, rapid changes in the treatment of type 1 diabetes have allowed for
commercialization of an “artificial pancreas” that is better described as a closed-loop …

The benchmark for assessing quality of long-term glycemic control and adjustment of
therapy is currently glycated hemoglobin (HbA1c). Despite its importance as an indicator for …

Closed-loop drug delivery promises autonomous control of pharmacotherapy through the
continuous monitoring of biomarker levels. For decades, researchers have strived for …

Microneedle (MN)-based electrochemical biosensors hold promising potential for
noninvasive continuous monitoring of interstitial fluid biomarkers. However, challenges …

Treatment of type 1 diabetes mellitus could be greatly improved by applying a closed-loop
control strategy to insulin delivery, also known as an artificial pancreas (AP). In this work, we …